Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Assessment of Cognitive Functioning Before and After Treatment With Duloxetine (DULOX)

This study has been completed.
Eli Lilly and Company
Information provided by (Responsible Party):
Prabha Sunderajan, University of Texas Southwestern Medical Center Identifier:
First received: July 2, 2009
Last updated: August 9, 2013
Last verified: August 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2007
  Primary Completion Date: September 2007 (Final data collection date for primary outcome measure)